Page results
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
Information about the integrated cancer care service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
Mr Laurence Watkins is a consultant neurosurgeon with sub-speciality interests in hydrocephalus, neurovascular surgery, intracranial pressure, chronic headache and neuro-endoscopy
-
Mr Jonathan Hyam is a consultant neurosurgeon who has an interest in headache, facial pain, movement disorders, and spinal pain.
-
This page provides information about post procedural care following a diagnostic angiogram or endovascular treatment and possible complications that may occur.
-
To mark the NHS’ 75th birthday on 5 July, the experiences of people working or volunteering in the NHS are being shared in a collection of online stories, including assistant chief nurse Dr Alison Finch.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Breathlessness (dyspnoea) is an unpleasant sensation of uncomfortable, rapid or difficult breathing.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023